Frost & Sullivan Names Javelin Pharmaceuticals Entrepreneurial Company Of The Year For Intranasal Therapeutics

PALO ALTO, Calif., Oct. 25 /PRNewswire/ -- Javelin Pharmaceuticals (Amex: JAV - News) has received the 2006 Frost & Sullivan Award for Entrepreneurial Company of the Year for its role as an emerging leader in intranasal therapeutics. Formal presentation of this award will take place at Frost & Sullivan’s annual Excellence in Pharmaceuticals & Life Sciences Awards Banquet in October.

MORE ON THIS TOPIC